SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹16 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹9.51 Cr |
What is the latest Contingent Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹6.07 Cr |
Mar2022 | ₹6.07 Cr |
Mar2021 | ₹6.07 Cr |
Mar2020 | ₹9.51 Cr |
How is Contingent Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 161.28 | |
Mar2023 | ₹6.07 Cr | 0.00 | |
Mar2022 | ₹6.07 Cr | 0.00 | |
Mar2021 | ₹6.07 Cr | -36.18 | |
Mar2020 | ₹9.51 Cr | - |
Compare Contingent Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,875.5 Cr | -5.8% | -1.5% | 80.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -5.8% |
-1.5% |
80.1% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses